Total results = 21
<div class="gs_r" style="z-index:400"><div class="gs_ggs gs_fl"><button type="button" id="gs_ggsB0" class="gs_btnFI gs_in_ib gs_btn_half"><span class="gs_wr"><span class="gs_bg"></span><span class="gs_lbl"></span><span class="gs_ico"></span></span></button><div class="gs_md_wp" id="gs_ggsW0"><a href="http://www.um.es/biomybiotec/web/Seminarios/2007/papers/Juan_Velasco_Malumbres%20et%20al%202007.pdf" class=yC1><span class="gs_ggsL"><span class=gs_ctg2>[PDF]</span> from um.es</span><span class="gs_ggsS">um.es <span class=gs_ctg2>[PDF]</span></span></a></div></div><div class="gs_ri"><h3 class="gs_rt"><span class="gs_ctc"><span class="gs_ct1">[PDF]</span><span class="gs_ct2">[PDF]</span></span> <a href="http://www.um.es/biomybiotec/web/Seminarios/2007/papers/Juan_Velasco_Malumbres%20et%20al%202007.pdf" class=yC0>CDK inhibitors in cancer therapy: what is next?</a></h3><div class="gs_a"><a href="/citations?user=PuGGz7EAAAAJ&amp;hl=en&amp;oi=sra">M Malumbres</a>, P Pevarello, M Barbacid&hellip; - Trends in  &hellip;, 2008 - um.es</div><div class="gs_rs">The pursuit for drugs that inhibit cyclin-dependent kinases (CDKs) has been an intense area <br>of research for more than 15 years. The first-generation inhibitors, Flavopiridol and CY-202, <br>are in late-stage clinical trials, but so far have demonstrated only modest activity. Several <b> ...</b></div><div class="gs_fl"><a href="/scholar?cites=3573135090892717260&amp;as_sdt=2005&amp;sciodt=0,5&amp;hl=en&amp;num=21">Cited by 121</a> <a href="/scholar?q=related:zLwkE29TljEJ:scholar.google.com/&amp;hl=en&amp;num=21&amp;as_sdt=0,5&amp;sciodt=0,5">Related articles</a> <a href="/scholar?cluster=3573135090892717260&amp;hl=en&amp;num=21&amp;as_sdt=0,5&amp;sciodt=0,5">All 6 versions</a> <a onclick="return gs_ocit(event,'zLwkE29TljEJ')" href="#" class="gs_nph">Cite</a> <div class="gs_rm_dd gs_nph"><a href="#" class="gs_rm_l" onclick="return gs_md_opn('gs_rm_md0', event)">More<span class="gs_ico"></span></a><div id="gs_rm_md0" class="gs_md_wn" style="display:none"><a href="http://scholar.googleusercontent.com/scholar?q=cache:zLwkE29TljEJ:scholar.google.com/&amp;hl=en&amp;num=21&amp;as_sdt=0,5&amp;sciodt=0,5" class="gs_md_li">View as HTML</a></div>  </div>  </div></div></div>
<div class="gs_r" style="z-index:399"><div class="gs_ggs gs_fl"><button type="button" id="gs_ggsB1" class="gs_btnFI gs_in_ib gs_btn_half"><span class="gs_wr"><span class="gs_bg"></span><span class="gs_lbl"></span><span class="gs_ico"></span></span></button><div class="gs_md_wp" id="gs_ggsW1"><a href="http://www.cmld.ku.edu/Publications/Dolle%20surveys/Survey%202005.pdf" class=yC3><span class="gs_ggsL"><span class=gs_ctg2>[PDF]</span> from ku.edu</span><span class="gs_ggsS">ku.edu <span class=gs_ctg2>[PDF]</span></span></a></div></div><div class="gs_ri"><h3 class="gs_rt"><a href="http://pubs.acs.org/doi/abs/10.1021/cc060095m" class=yC2>Comprehensive survey of combinatorial library synthesis: 2005</a></h3><div class="gs_a">RE Dolle, B Le Bourdonnec, GA Morales&hellip; - Journal of  &hellip;, 2006 - ACS Publications</div><div class="gs_rs">Caspase-3 Inhibitors. Recent studies toward understanding the molecular mechanisms of apoptosis <br>have highlighted the importance of a group of cysteinyl aspartate specific proteases, the <br>caspases, in the programmed cell death process. To date, 14 mammalian members of <b> ...</b> </div><div class="gs_fl"><a href="/scholar?cites=14444931084679237075&amp;as_sdt=2005&amp;sciodt=0,5&amp;hl=en&amp;num=21">Cited by 84</a> <a href="/scholar?q=related:081N-0m0dsgJ:scholar.google.com/&amp;hl=en&amp;num=21&amp;as_sdt=0,5&amp;sciodt=0,5">Related articles</a> <a href="/scholar?cluster=14444931084679237075&amp;hl=en&amp;num=21&amp;as_sdt=0,5&amp;sciodt=0,5">All 5 versions</a> <a onclick="return gs_ocit(event,'081N-0m0dsgJ')" href="#" class="gs_nph">Cite</a></div></div></div>
<div class="gs_r" style="z-index:398"><div class="gs_ri"><h3 class="gs_rt"><a href="http://ukpmc.ac.uk/abstract/MED/17073695" class=yC4>Structure selection for protein kinase docking and virtual screening: homology models or crystal structures?</a></h3><div class="gs_a">WM Rockey, <a href="/citations?user=i7ENStwAAAAJ&amp;hl=en&amp;oi=sra">AH Elcock</a> - Current protein &amp; peptide science, 2006 - ukpmc.ac.uk</div><div class="gs_rs">There is currently far more sequence information than structural information available, and <br>the ability to use homology models for virtual screening applications is desirable in many <br>cases where structures have not yet been solved. This review focuses on the application <b> ...</b></div><div class="gs_fl"><a href="/scholar?cites=4724990323135712293&amp;as_sdt=2005&amp;sciodt=0,5&amp;hl=en&amp;num=21">Cited by 45</a> <a href="/scholar?q=related:JYypMaqJkkEJ:scholar.google.com/&amp;hl=en&amp;num=21&amp;as_sdt=0,5&amp;sciodt=0,5">Related articles</a> <a href="http://direct.bl.uk/research/0F/12/RN194890680.html?source=googlescholar" class="gs_nph" class=yC5>BL Direct</a> <a href="/scholar?cluster=4724990323135712293&amp;hl=en&amp;num=21&amp;as_sdt=0,5&amp;sciodt=0,5">All 4 versions</a> <a onclick="return gs_ocit(event,'JYypMaqJkkEJ')" href="#" class="gs_nph">Cite</a> <div class="gs_rm_dd gs_nph"><a href="#" class="gs_rm_l" onclick="return gs_md_opn('gs_rm_md2', event)">More<span class="gs_ico"></span></a><div id="gs_rm_md2" class="gs_md_wn" style="display:none"><a href="http://scholar.googleusercontent.com/scholar?q=cache:JYypMaqJkkEJ:scholar.google.com/&amp;hl=en&amp;num=21&amp;as_sdt=0,5&amp;sciodt=0,5" class="gs_md_li">Cached</a></div>  </div>  </div></div></div>
<div class="gs_r" style="z-index:397"><div class="gs_ggs gs_fl"><button type="button" id="gs_ggsB3" class="gs_btnFI gs_in_ib gs_btn_half"><span class="gs_wr"><span class="gs_bg"></span><span class="gs_lbl"></span><span class="gs_ico"></span></span></button><div class="gs_md_wp" id="gs_ggsW3"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2751441/" class=yC7><span class="gs_ggsL"><span class=gs_ctg2>[HTML]</span> from nih.gov</span><span class="gs_ggsS">nih.gov <span class=gs_ctg2>[HTML]</span></span></a></div></div><div class="gs_ri"><h3 class="gs_rt"><a href="http://www.springerlink.com/index/C38X3U3871WM6K2X.pdf" class=yC6>Selectivity and potency of cyclin-dependent kinase inhibitors</a></h3><div class="gs_a">J Sridhar, N Akula, N Pattabiraman - The aaps journal, 2006 - Springer</div><div class="gs_rs">Abstract Members of the cyclin-dependent kinase (CDK) family play key roles in various <br>cellular processes. There are 11 members of the CDK family known till now. CDKs are <br>activated by forming noncovalent complexes with cyclins such as A-, B-, C-, D-(D1, D2, <b> ...</b></div><div class="gs_fl"><a href="/scholar?cites=2991848504622995122&amp;as_sdt=2005&amp;sciodt=0,5&amp;hl=en&amp;num=21">Cited by 40</a> <a href="/scholar?q=related:slbWC10uhSkJ:scholar.google.com/&amp;hl=en&amp;num=21&amp;as_sdt=0,5&amp;sciodt=0,5">Related articles</a> <a href="/scholar?cluster=2991848504622995122&amp;hl=en&amp;num=21&amp;as_sdt=0,5&amp;sciodt=0,5">All 12 versions</a> <a onclick="return gs_ocit(event,'slbWC10uhSkJ')" href="#" class="gs_nph">Cite</a></div></div></div>
<div class="gs_r" style="z-index:396"><div class="gs_ri"><h3 class="gs_rt"><a href="http://onlinelibrary.wiley.com/doi/10.1002/adsc.200700133/abstract" class=yC8>Applicability Aspects of Transition MetalâCatalyzed Aromatic Amination Protocols in Medicinal Chemistry</a></h3><div class="gs_a">S Tasler, J Mies, M Lang - Advanced Synthesis &amp; Catalysis, 2007 - Wiley Online Library</div><div class="gs_rs">Abstract The application of palladium-and copper-catalyzed reactions for the aromatic <br>amination of pharmacologically relevant scaffolds is investigated. The focus is set on the <br>scope of several protocols for the introduction of amines of broad structural diversity, <b> ...</b></div><div class="gs_fl"><a href="/scholar?cites=1426973501446147479&amp;as_sdt=2005&amp;sciodt=0,5&amp;hl=en&amp;num=21">Cited by 28</a> <a href="/scholar?q=related:l82X0dagzRMJ:scholar.google.com/&amp;hl=en&amp;num=21&amp;as_sdt=0,5&amp;sciodt=0,5">Related articles</a> <a href="http://direct.bl.uk/research/54/56/RN218049823.html?source=googlescholar" class="gs_nph" class=yC9>BL Direct</a> <a href="/scholar?cluster=1426973501446147479&amp;hl=en&amp;num=21&amp;as_sdt=0,5&amp;sciodt=0,5">All 3 versions</a> <a onclick="return gs_ocit(event,'l82X0dagzRMJ')" href="#" class="gs_nph">Cite</a></div></div></div>
<div class="gs_r" style="z-index:395"><div class="gs_ri"><h3 class="gs_rt"><a href="http://www.springerlink.com/index/l2j0q312t5jrw3pv.pdf" class=yCA>Can we use docking and scoring for hit-to-lead optimization?</a></h3><div class="gs_a">IJ Enyedy, WJ Egan - Journal of computer-aided molecular design, 2008 - Springer</div><div class="gs_rs">Abstract Docking and scoring is currently one of the tools used for hit finding and hit-to-lead <br>optimization when structural information about the target is known. Docking scores have <br>been found useful for optimizing ligand binding to reproduce experimentally observed <b> ...</b></div><div class="gs_fl"><a href="/scholar?cites=5318953818463418827&amp;as_sdt=2005&amp;sciodt=0,5&amp;hl=en&amp;num=21">Cited by 25</a> <a href="/scholar?q=related:yzk4HlG40EkJ:scholar.google.com/&amp;hl=en&amp;num=21&amp;as_sdt=0,5&amp;sciodt=0,5">Related articles</a> <a href="http://direct.bl.uk/research/4B/4E/RN225911836.html?source=googlescholar" class="gs_nph" class=yCB>BL Direct</a> <a href="/scholar?cluster=5318953818463418827&amp;hl=en&amp;num=21&amp;as_sdt=0,5&amp;sciodt=0,5">All 5 versions</a> <a onclick="return gs_ocit(event,'yzk4HlG40EkJ')" href="#" class="gs_nph">Cite</a></div></div></div>
<div class="gs_r" style="z-index:394"><div class="gs_ri"><h3 class="gs_rt"><a href="http://www.sciencedirect.com/science/article/pii/S0968089608002599" class=yCC>Synthesis of 3, 5-bis (2-indolyl) pyridine and 3-[(2-indolyl)-5-phenyl] pyridine derivatives as CDK inhibitors and cytotoxic agents</a></h3><div class="gs_a">U Jacquemard, N Dias, A Lansiaux, C Bailly&hellip; - Bioorganic &amp; medicinal  &hellip;, 2008 - Elsevier</div><div class="gs_rs">We here report the synthesis and biological evaluation of new 3, 5-bis (2-indolyl) pyridine <br>and 3-[(2-indolyl)-5-phenyl] pyridine designed as potential CDK inhibitors. Indole, 5-<br>hydroxyindole, and phenol derivatives were used to generate three substitutions of the <b> ...</b></div><div class="gs_fl"><a href="/scholar?cites=3840304996073215090&amp;as_sdt=2005&amp;sciodt=0,5&amp;hl=en&amp;num=21">Cited by 22</a> <a href="/scholar?q=related:chQaEAyBSzUJ:scholar.google.com/&amp;hl=en&amp;num=21&amp;as_sdt=0,5&amp;sciodt=0,5">Related articles</a> <a href="/scholar?cluster=3840304996073215090&amp;hl=en&amp;num=21&amp;as_sdt=0,5&amp;sciodt=0,5">All 8 versions</a> <a onclick="return gs_ocit(event,'chQaEAyBSzUJ')" href="#" class="gs_nph">Cite</a></div></div></div>
<div class="gs_r" style="z-index:393"><div class="gs_ri"><h3 class="gs_rt"><a href="http://onlinelibrary.wiley.com/doi/10.1002/ardp.200800223/abstract" class=yCD>Synthesis and biological evaluation of some novel polysubstituted pyrimidine derivatives as potential antimicrobial and anticancer agents</a></h3><div class="gs_a">SAF Rostom, H Ashour&hellip; - Archiv der  &hellip;, 2009 - Wiley Online Library</div><div class="gs_rs">Abstract Synthesis and evaluation of the antimicrobial and cytotoxic activity of two series of <br>polysubstituted pyrimidines comprising the thioether functionality and other <br>pharmacophores, reported to contribute to various chemotherapeutic activities are <b> ...</b></div><div class="gs_fl"><a href="/scholar?cites=7991836056982115488&amp;as_sdt=2005&amp;sciodt=0,5&amp;hl=en&amp;num=21">Cited by 15</a> <a href="/scholar?q=related:oNSTH4206G4J:scholar.google.com/&amp;hl=en&amp;num=21&amp;as_sdt=0,5&amp;sciodt=0,5">Related articles</a> <a href="/scholar?cluster=7991836056982115488&amp;hl=en&amp;num=21&amp;as_sdt=0,5&amp;sciodt=0,5">All 6 versions</a> <a onclick="return gs_ocit(event,'oNSTH4206G4J')" href="#" class="gs_nph">Cite</a></div></div></div>
<div class="gs_r" style="z-index:392"><div class="gs_ggs gs_fl"><button type="button" id="gs_ggsB8" class="gs_btnFI gs_in_ib gs_btn_half"><span class="gs_wr"><span class="gs_bg"></span><span class="gs_lbl"></span><span class="gs_ico"></span></span></button><div class="gs_md_wp" id="gs_ggsW8"><a href="http://downloads.tswj.com/2006/741509.pdf" class=yCF><span class="gs_ggsL"><span class=gs_ctg2>[PDF]</span> from tswj.com</span><span class="gs_ggsS">tswj.com <span class=gs_ctg2>[PDF]</span></span></a></div></div><div class="gs_ri"><h3 class="gs_rt"><span class="gs_ctc"><span class="gs_ct1">[PDF]</span><span class="gs_ct2">[PDF]</span></span> <a href="http://downloads.tswj.com/2006/741509.pdf" class=yCE>Using protein homology models for structure-based studies: approaches to model refinement</a></h3><div class="gs_a"><a href="/citations?user=cHhWMVwAAAAJ&amp;hl=en&amp;oi=sra">V Kairys</a>, <a href="/citations?user=ijlu9YoAAAAJ&amp;hl=en&amp;oi=sra">MK Gilson</a>, <a href="/citations?user=iMVa6YQAAAAJ&amp;hl=en&amp;oi=sra">MX Fernandes</a> - ScientificWorldJournal, 2006 - downloads.tswj.com</div><div class="gs_rs">Homology modeling is a computational methodology to assign a 3-D structure to a target <br>protein when experimental data are not available. The methodology uses another protein <br>with a known structure that shares some sequence identity with the target as a template. <b> ...</b></div><div class="gs_fl"><a href="/scholar?cites=13223416433535739973&amp;as_sdt=2005&amp;sciodt=0,5&amp;hl=en&amp;num=21">Cited by 10</a> <a href="/scholar?q=related:Rej1hS8Dg7cJ:scholar.google.com/&amp;hl=en&amp;num=21&amp;as_sdt=0,5&amp;sciodt=0,5">Related articles</a> <a href="/scholar?cluster=13223416433535739973&amp;hl=en&amp;num=21&amp;as_sdt=0,5&amp;sciodt=0,5">All 8 versions</a> <a onclick="return gs_ocit(event,'Rej1hS8Dg7cJ')" href="#" class="gs_nph">Cite</a> <div class="gs_rm_dd gs_nph"><a href="#" class="gs_rm_l" onclick="return gs_md_opn('gs_rm_md8', event)">More<span class="gs_ico"></span></a><div id="gs_rm_md8" class="gs_md_wn" style="display:none"><a href="http://scholar.googleusercontent.com/scholar?q=cache:Rej1hS8Dg7cJ:scholar.google.com/&amp;hl=en&amp;num=21&amp;as_sdt=0,5&amp;sciodt=0,5" class="gs_md_li">View as HTML</a></div>  </div>  </div></div></div>
<div class="gs_r" style="z-index:391"><div class="gs_ri"><h3 class="gs_rt"><a href="http://onlinelibrary.wiley.com/doi/10.1002/cmdc.200600199/full" class=yC10>Macrocyclic Aminopyrimidines as Multitarget CDK and VEGFâR Inhibitors with Potent Antiproliferative Activities</a></h3><div class="gs_a">U LÃ¼cking, G Siemeister, M SchÃ¤fer, H Briem&hellip; -  &hellip;, 2007 - Wiley Online Library</div><div class="gs_rs">Abstract X-ray structures from CDK2âaminopyrimidine inhibitor complexes led to the idea to <br>stabilize the active conformation of aminopyrimidine inhibitors by incorporating the <br>recognition site into a macrocyclic framework. A modular synthesis approach that relies on <b> ...</b></div><div class="gs_fl"><a href="/scholar?cites=3417457282837143745&amp;as_sdt=2005&amp;sciodt=0,5&amp;hl=en&amp;num=21">Cited by 10</a> <a href="/scholar?q=related:wWCU0ko_bS8J:scholar.google.com/&amp;hl=en&amp;num=21&amp;as_sdt=0,5&amp;sciodt=0,5">Related articles</a> <a href="/scholar?cluster=3417457282837143745&amp;hl=en&amp;num=21&amp;as_sdt=0,5&amp;sciodt=0,5">All 5 versions</a> <a onclick="return gs_ocit(event,'wWCU0ko_bS8J')" href="#" class="gs_nph">Cite</a></div></div></div>
<div class="gs_r" style="z-index:390"><div class="gs_ri"><h3 class="gs_rt"><a href="http://www.springerlink.com/index/V1645Q6654T77413.pdf" class=yC11>Combinatorial chemistry in cancer research</a></h3><div class="gs_a">A Messeguer, N CortÃ©s - Clinical and Translational Oncology, 2007 - Springer</div><div class="gs_rs">Abstract Among the different strategies to treat cancer, chemotherapy approaches are the <br>subject of intense research efforts. There is still a high demand for new anticancer drugs <br>exhibiting improved efficiency and selectivity for their use in combined therapy strategies. <b> ...</b></div><div class="gs_fl"><a href="/scholar?cites=10767264786254747679&amp;as_sdt=2005&amp;sciodt=0,5&amp;hl=en&amp;num=21">Cited by 7</a> <a href="/scholar?q=related:H1hJk0YCbZUJ:scholar.google.com/&amp;hl=en&amp;num=21&amp;as_sdt=0,5&amp;sciodt=0,5">Related articles</a> <a href="http://direct.bl.uk/research/3D/50/RN205541608.html?source=googlescholar" class="gs_nph" class=yC12>BL Direct</a> <a href="/scholar?cluster=10767264786254747679&amp;hl=en&amp;num=21&amp;as_sdt=0,5&amp;sciodt=0,5">All 6 versions</a> <a onclick="return gs_ocit(event,'H1hJk0YCbZUJ')" href="#" class="gs_nph">Cite</a></div></div></div>
<div class="gs_r" style="z-index:389"><div class="gs_ri"><h3 class="gs_rt"><a href="http://www.sciencedirect.com/science/article/pii/S0040403906009580" class=yC13>Efficient Pd-catalyzed synthesis of 2-arylaminopyrimidines via microwave irradiation</a></h3><div class="gs_a">HQ Zhang, Z Xia, A Vasudevan, SW Djuric - Tetrahedron letters, 2006 - Elsevier</div><div class="gs_rs">An efficient method for the synthesis of 2-arylaminopyrimidines via microwave assisted, Pd-<br>mediated amination of 2-chloropyrimidine is reported. This method is superior to the <br>classical heating process, particularly when one of starting materials is a heteroarylamine.</div><div class="gs_fl"><a href="/scholar?cites=8710146268443404213&amp;as_sdt=2005&amp;sciodt=0,5&amp;hl=en&amp;num=21">Cited by 7</a> <a href="/scholar?q=related:tWdDAOKn4HgJ:scholar.google.com/&amp;hl=en&amp;num=21&amp;as_sdt=0,5&amp;sciodt=0,5">Related articles</a> <a href="/scholar?cluster=8710146268443404213&amp;hl=en&amp;num=21&amp;as_sdt=0,5&amp;sciodt=0,5">All 4 versions</a> <a onclick="return gs_ocit(event,'tWdDAOKn4HgJ')" href="#" class="gs_nph">Cite</a></div></div></div>
<div class="gs_r" style="z-index:388"><div class="gs_ri"><h3 class="gs_rt"><a href="http://www.springerlink.com/index/P2876H7795361708.pdf" class=yC14>Progress in the development of agents to control the cell cycle</a></h3><div class="gs_a">KJ Moriarty, H Koblish, DL Johnson, RA Galemmo - Cancer, 2007 - Springer</div><div class="gs_rs">Inhibitors of the kinases controlling the cell cycle have emerged as an important therapeutic <br>modality for the treatment of cancer. Drug discovery efforts have focused on inhibitors of the <br>cyclin-dependent kinases, the Aurora kinases, and Polo-like kinases. Agents for each <b> ...</b></div><div class="gs_fl"><a href="/scholar?cites=12283935368796206088&amp;as_sdt=2005&amp;sciodt=0,5&amp;hl=en&amp;num=21">Cited by 5</a> <a href="/scholar?q=related:CHT0hCJOeaoJ:scholar.google.com/&amp;hl=en&amp;num=21&amp;as_sdt=0,5&amp;sciodt=0,5">Related articles</a> <a onclick="return gs_ocit(event,'CHT0hCJOeaoJ')" href="#" class="gs_nph">Cite</a></div></div></div>
<div class="gs_r" style="z-index:387"><div class="gs_ri"><h3 class="gs_rt"><a href="http://onlinelibrary.wiley.com/doi/10.1002/9780470524961.ch17/summary" class=yC15>Approaches to Kinase Homology Modeling: Successes and Considerations for the Structural Kinome</a></h3><div class="gs_a">VA Feher, JD Lawson - Kinase Inhibitor Drugs, 2009 - Wiley Online Library</div><div class="gs_rs">This chapter focuses on the characteristics of protein kinases that avail themselves to <br>homology modeling (also known as comparative protein modeling) as part of a structure-<br>based drug design/discovery (SBDD) process. We explore the extent of the kinome <b> ...</b></div><div class="gs_fl"><a href="/scholar?q=related:X_NGCMEnfz0J:scholar.google.com/&amp;hl=en&amp;num=21&amp;as_sdt=0,5&amp;sciodt=0,5">Related articles</a> <a href="/scholar?cluster=4431304268376896351&amp;hl=en&amp;num=21&amp;as_sdt=0,5&amp;sciodt=0,5">All 3 versions</a> <a onclick="return gs_ocit(event,'X_NGCMEnfz0J')" href="#" class="gs_nph">Cite</a></div></div></div>
<div class="gs_r" style="z-index:386"><div class="gs_ggs gs_fl"><button type="button" id="gs_ggsB14" class="gs_btnFI gs_in_ib gs_btn_half"><span class="gs_wr"><span class="gs_bg"></span><span class="gs_lbl"></span><span class="gs_ico"></span></span></button><div class="gs_md_wp" id="gs_ggsW14"><a href="http://etheses.saurashtrauniversity.edu/527/1/vagadia_hc_thesis_chemistry.pdf" class=yC17><span class="gs_ggsL"><span class=gs_ctg2>[PDF]</span> from saurashtrauniversity.edu</span><span class="gs_ggsS">saurashtrauniversity.edu <span class=gs_ctg2>[PDF]</span></span></a></div></div><div class="gs_ri"><h3 class="gs_rt"><span class="gs_ctc"><span class="gs_ct1">[PDF]</span><span class="gs_ct2">[PDF]</span></span> <a href="http://etheses.saurashtrauniversity.edu/527/1/vagadia_hc_thesis_chemistry.pdf" class=yC16>Discovering The New Chemical Entities of Therapeutic Interest</a></h3><div class="gs_a">HC Vagadia - 2005 - etheses.saurashtrauniversity.edu</div><div class="gs_rs">Page 1. Saurashtra University Re â Accredited Grade &#39;B&#39; by NAAC (CGPA 2.93) Vagadia, Harsha<br>C., 2005, âDiscovering The New Chemical Entities of Therapeutic Interestâ, thesis PhD, Saurashtra<br>University http://etheses.saurashtrauniversity.edu/id/eprint/527 <b>...</b> </div><div class="gs_fl"><a href="/scholar?q=related:isWcKlmCOFIJ:scholar.google.com/&amp;hl=en&amp;num=21&amp;as_sdt=0,5&amp;sciodt=0,5">Related articles</a> <a onclick="return gs_ocit(event,'isWcKlmCOFIJ')" href="#" class="gs_nph">Cite</a> <div class="gs_rm_dd gs_nph"><a href="#" class="gs_rm_l" onclick="return gs_md_opn('gs_rm_md14', event)">More<span class="gs_ico"></span></a><div id="gs_rm_md14" class="gs_md_wn" style="display:none"><a href="http://scholar.googleusercontent.com/scholar?q=cache:isWcKlmCOFIJ:scholar.google.com/&amp;hl=en&amp;num=21&amp;as_sdt=0,5&amp;sciodt=0,5" class="gs_md_li">View as HTML</a></div>  </div>  </div></div></div>
<div class="gs_r" style="z-index:385"><div class="gs_ggs gs_fl"><button type="button" id="gs_ggsB15" class="gs_btnFI gs_in_ib gs_btn_half"><span class="gs_wr"><span class="gs_bg"></span><span class="gs_lbl"></span><span class="gs_ico"></span></span></button><div class="gs_md_wp" id="gs_ggsW15"><a href="http://etheses.saurashtrauniversity.edu/526/1/shekhada_nv_thesis_chemistry.pdf" class=yC19><span class="gs_ggsL"><span class=gs_ctg2>[PDF]</span> from saurashtrauniversity.edu</span><span class="gs_ggsS">saurashtrauniversity.edu <span class=gs_ctg2>[PDF]</span></span></a></div></div><div class="gs_ri"><h3 class="gs_rt"><span class="gs_ctc"><span class="gs_ct1">[PDF]</span><span class="gs_ct2">[PDF]</span></span> <a href="http://etheses.saurashtrauniversity.edu/526/1/shekhada_nv_thesis_chemistry.pdf" class=yC18>Design and Synthesis of Heterocycles of Pharmaceutical Interest</a></h3><div class="gs_a">NV Shekhada - 2006 - etheses.saurashtrauniversity.edu</div><div class="gs_rs">Research in the field of pharmaceutical has its most important task in the development of <br>new better drugs and their successful introduction into clinical practice. Central to these <br>efforts, accordingly stand the search for pharmaceutical substances and preparation <b> ...</b></div><div class="gs_fl"><a href="/scholar?q=related:2N41RH_srH4J:scholar.google.com/&amp;hl=en&amp;num=21&amp;as_sdt=0,5&amp;sciodt=0,5">Related articles</a> <a onclick="return gs_ocit(event,'2N41RH_srH4J')" href="#" class="gs_nph">Cite</a> <div class="gs_rm_dd gs_nph"><a href="#" class="gs_rm_l" onclick="return gs_md_opn('gs_rm_md15', event)">More<span class="gs_ico"></span></a><div id="gs_rm_md15" class="gs_md_wn" style="display:none"><a href="http://scholar.googleusercontent.com/scholar?q=cache:2N41RH_srH4J:scholar.google.com/&amp;hl=en&amp;num=21&amp;as_sdt=0,5&amp;sciodt=0,5" class="gs_md_li">View as HTML</a></div>  </div>  </div></div></div>
<div class="gs_r" style="z-index:384"><div class="gs_ri"><h3 class="gs_rt"><a href="http://pubs.acs.org/doi/abs/10.1021/jo201425q" class=yC1A>Direct, Metal-Free Amination of Heterocyclic Amides/Ureas with NH-Heterocycles and N-Substituted Anilines in POCl3</a></h3><div class="gs_a">X Deng, A Roessler, I Brdar, R Faessler&hellip; - The Journal of  &hellip;, 2011 - ACS Publications</div><div class="gs_rs">A POCl3-mediated, direct amination reaction of heterocyclic amides/ureas with NH-<br>heterocycles or N-substituted anilines is described. Compared to the existing methods, this <br>operationally simple protocol provides unique reactivity and functional group compatibility <b> ...</b></div><div class="gs_fl"><a href="/scholar?q=related:uAiFdlDYGNkJ:scholar.google.com/&amp;hl=en&amp;num=21&amp;as_sdt=0,5&amp;sciodt=0,5">Related articles</a> <a href="/scholar?cluster=15643491145768831160&amp;hl=en&amp;num=21&amp;as_sdt=0,5&amp;sciodt=0,5">All 4 versions</a> <a onclick="return gs_ocit(event,'uAiFdlDYGNkJ')" href="#" class="gs_nph">Cite</a></div></div></div>
<div class="gs_r" style="z-index:383"><div class="gs_ri"><h3 class="gs_rt"><span class="gs_ctu"><span class="gs_ct1">[CITATION]</span><span class="gs_ct2">[C]</span></span> Volume 0, Number 0---Issue Number Is In Error---</h3><div class="gs_a">RE Dolle, B Le Bourdonnec, GA Morales, KJ Moriarty&hellip; - 1998</div><div class="gs_fl"><a href="/scholar?q=related:ts4IoiCUI9IJ:scholar.google.com/&amp;hl=en&amp;num=21&amp;as_sdt=0,5&amp;sciodt=0,5">Related articles</a> <a onclick="return gs_ocit(event,'ts4IoiCUI9IJ')" href="#" class="gs_nph">Cite</a></div></div></div>
<div class="gs_r" style="z-index:382"><div class="gs_ri"><h3 class="gs_rt"><span class="gs_ctu"><span class="gs_ct1">[CITATION]</span><span class="gs_ct2">[C]</span></span> Combinatorial Chemistry Online: Volume 7, Issue 5, May 2005</h3><div class="gs_a">NK Terrett - Combinatorial Chemistry-an Online Journal, 2005 - Elsevier</div><div class="gs_fl"><a href="/scholar?q=related:Zd5Kx5rzUmYJ:scholar.google.com/&amp;hl=en&amp;num=21&amp;as_sdt=0,5&amp;sciodt=0,5">Related articles</a> <a onclick="return gs_ocit(event,'Zd5Kx5rzUmYJ')" href="#" class="gs_nph">Cite</a></div></div></div>
<div class="gs_r" style="z-index:381"><div class="gs_ggs gs_fl"><button type="button" id="gs_ggsB19" class="gs_btnFI gs_in_ib gs_btn_half"><span class="gs_wr"><span class="gs_bg"></span><span class="gs_lbl"></span><span class="gs_ico"></span></span></button><div class="gs_md_wp" id="gs_ggsW19"><a href="http://www.aapsj.org/view.asp?art=aapsj080125" class=yC1C><span class="gs_ggsL"><span class=gs_ctg2>[HTML]</span> from aapsj.org</span><span class="gs_ggsS">aapsj.org <span class=gs_ctg2>[HTML]</span></span></a></div></div><div class="gs_ri"><h3 class="gs_rt"><span class="gs_ctc"><span class="gs_ct1">[HTML]</span><span class="gs_ct2">[HTML]</span></span> <a href="http://www.aapsj.org/view.asp?art=aapsj080125" class=yC1B>Sridhar J, Akula N, Pattabiraman N. Selectivity and Potency of Cyclin-dependent Kinase Inhibitors. AAPS Journal. 2006; 8 (1): E204-E221. DOI: 10.1208/ &hellip;</a></h3><div class="gs_a">J Sridhar - aapsj.org</div><div class="gs_rs">Abstract Members of the cyclin-dependent kinase (CDK) family play key roles in various <br>cellular processes. There are 11 members of the CDK family known till now. CDKs are <br>activated by forming noncovalent complexes with cyclins such as A-, B-, C-, D-(D1, D2, <b> ...</b></div><div class="gs_fl"><a href="/scholar?q=related:fGWN8mA3OiUJ:scholar.google.com/&amp;hl=en&amp;num=21&amp;as_sdt=0,5&amp;sciodt=0,5">Related articles</a> <a onclick="return gs_ocit(event,'fGWN8mA3OiUJ')" href="#" class="gs_nph">Cite</a> <div class="gs_rm_dd gs_nph"><a href="#" class="gs_rm_l" onclick="return gs_md_opn('gs_rm_md19', event)">More<span class="gs_ico"></span></a><div id="gs_rm_md19" class="gs_md_wn" style="display:none"><a href="http://scholar.googleusercontent.com/scholar?q=cache:fGWN8mA3OiUJ:scholar.google.com/&amp;hl=en&amp;num=21&amp;as_sdt=0,5&amp;sciodt=0,5" class="gs_md_li">Cached</a></div>  </div>  </div></div></div>
<div class="gs_r" style="z-index:380"><div class="gs_ri"><h3 class="gs_rt"><span class="gs_ctc"><span class="gs_ct1">[CITATION]</span><span class="gs_ct2">[C]</span></span> <a href="http://www.cqvip.com/qk/90654a/2012011/43834410.html" class=yC1D>å« 4-(å§å¶-2-æ°¨åº) è¯ç£ºé°èºè¯æå¢çåè³åºè²ç±»ååç©çåæåæå¢æ®æ´»æ§</a></h3><div class="gs_a">ç¥å®è¾ï¼ è£çï¼ ç±³æï¼ ç¿é« - æ²é³è¯ç§å¤§å­¦å­¦æ¥, 2012 - cqvip.com</div><div class="gs_rs">ç®çè®¾è®¡å¹¶åæå«4-(å§å¶-2-æ°¨åº) è¯ç£ºé°èºè¯æå¢çåè³åºè²ç±»ååç©, <br>è¯ä»·å¶ä½å¤æå¢æ®æ´»æ§. æ¹æ³ä»¥å¯¹ç¡åºæº´èåæ æ°´ååªä¸ºèµ·å§åæ, ç»5 æ­¥ååºåæç®æ ååç©; <br>ä»¥sorafenib ä¸ºé³æ§å¯¹ç§è¯, éç¨MTT æ³æµå®äºç®æ ååç©å¯¹äººèçç»èSMMC-7721 åäººé<b> ...</b></div><div class="gs_fl"><a onclick="return gs_ocit(event,'BMUokxOQsJoJ')" href="#" class="gs_nph">Cite</a></div></div></div>
